1- 289-270-4933
Innovative Swiss-German R&D firm seeks funding partner for advanced medical cannabis vape technology
Highly-specialized, Swiss-German R&D firm first to market with disruptive, advanced medical inhaler for clean cannabis extracts seeks strategic funding partner
Listing ID:
15959335429
Licence(s) Held:
N/A
Seeking strategic equity partner to fund up to ~ €1.5 million for accelerated development
Listing Details:
A German R&D company focused on developing vaporizer technology as a medical device for liquid cannabis extracts aiming to solve the core issues medical inhalation today
The technology excels in precisely evaporating small to high dosages in a single inhalation, ensuring optimal particle size for effective lung delivery
Different dosages will rely on dose specific cartridges, all working on the same inhalation platform technology
The technology is currently patent-pending, with anticipated patent grants in Europe, USA and Australia slated in 2024 or 2025
ISO 13485 certification to be certified in Q2 2024
Experienced, industry-leading international team possessing profound knowledge in medical/pharma R&D, expertise in inhalation technologies, and a strong background in the medical cannabis regulatory field
The company specializes in the development and sale of customized medical inhalers, achieving sustainable profits through strategic licensing agreements with pharmaceutical customers
Company is seeking strategic funding partner for accelerated development and bringing the product to market
15959335429